Supernus to Participate in Upcoming September Investor Conferences

Rhea-AI Summary

Supernus Pharmaceuticals, focused on CNS disease treatments, will participate in three key virtual investor conferences in September 2021.

• Citi’s 16th Annual BioPharma Virtual Conference: September 9, 2021, one-on-one meetings.
• Wells Fargo 2021 Virtual Healthcare Conference: September 10, 2021, presentation at 9:20 a.m. ET.
• Morgan Stanley 19th Annual Global Healthcare Conference: September 15, 2021, fireside chat at 11:45 a.m. ET.

Webcasts available on their website post-conference.

ROCKVILLE, Md., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company’s management will participate and host investor meetings in the following upcoming September 2021 virtual investor conferences.

Citi’s 16^th Annual BioPharma Virtual Conference
Date: Thursday, September 9, 2021
Participation Type: One-on-one meetings

Wells Fargo 2021 Virtual Healthcare Conference
Date: Friday, September 10, 2021
Participation Type: Presentation
Presentation Time: 9:20 a.m. ET

Morgan Stanley 19^th Annual Global Healthcare Conference
Date: Wednesday, September 15, 2021
Participation Type: Fireside Chat
Presentation Time: 11:45 a.m. ET

A live webcast of the events can be accessed by visiting Events & Presentations in the Investor Relations section on the Company's website at www.supernus.com. An archived replay of each webcast will be available for 60 days on the Company's website after the respective conference.

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.

Our diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, ADHD, hypomobility in Parkinson’s disease, cervical dystonia and chronic sialorrhea. We are developing a broad range of novel CNS product candidates including new potential treatments for hypomobility in Parkinson’s disease, epilepsy, depression and rare CNS disorders.

For more information, please visit www.supernus.com.

CONTACTS:

Jack A. Khattar, President and Chief Executive Officer
Supernus Pharmaceuticals, Inc.
Tel: (301) 838-2591

or

INVESTOR CONTACT:
Peter Vozzo
Westwicke/ICR
Office: (443) 213-0505
Mobile: (443) 377-4767
Email: peter.vozzo@westwicke.com

FAQ

What are the upcoming investor conferences for Supernus Pharmaceuticals in September 2021?

Supernus Pharmaceuticals will participate in the Citi’s 16th Annual BioPharma Virtual Conference on September 9, the Wells Fargo 2021 Virtual Healthcare Conference on September 10, and the Morgan Stanley 19th Annual Global Healthcare Conference on September 15, 2021.

What is the participation format for Supernus Pharmaceuticals at the Citi conference?

At the Citi’s 16th Annual BioPharma Virtual Conference, Supernus Pharmaceuticals will engage in one-on-one meetings.

What time will Supernus Pharmaceuticals present at the Wells Fargo conference?

Supernus Pharmaceuticals will present at the Wells Fargo 2021 Virtual Healthcare Conference on September 10, 2021, at 9:20 a.m. ET.

When will Supernus Pharmaceuticals host a fireside chat?

Supernus Pharmaceuticals will host a fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on September 15, 2021, at 11:45 a.m. ET.

Where can I find the webcasts of Supernus Pharmaceuticals' investor events?

The live webcasts of Supernus Pharmaceuticals' investor events can be accessed through the Investor Relations section of their website.